Pular para o conteúdo
Osteogenesis imperfecta
ORPHA:666CID-10 · Q78.0CID-11 · LD24.K0DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Sistema ósseoInício todas idadesHerança AD/AR/XL
Também conhecida comoOsteogénese ImperfeitaDoença de LobsteinDoença de Ekman-LobsteinSíndrome dos ossos de cristalOI
Sinônimos clínicos: Doença de Lobstein · Doença dos ossos de vidro · OI · +3

A osteogênese imperfeita (OI) compreende um grupo heterogêneo de doenças genéticas caracterizadas por aumento da fragilidade óssea, baixa massa óssea e suscetibilidade a fraturas ósseas com gravidade variável.

Última verificação: Fonte: verificadoEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A osteogênese imperfeita (OI) é um grupo de distúrbios genéticos que afetam principalmente os ossos. O termo “osteogênese imperfeita” significa formação óssea imperfeita. Pessoas com essa condição têm ossos que se quebram (fratura) facilmente, muitas vezes a partir de trauma leve ou sem causa aparente. Fraturas múltiplas são comuns e, em casos graves, podem ocorrer mesmo antes do nascimento. Casos mais leves podem envolver apenas algumas fraturas ao longo da vida da pessoa.

Existem pelo menos 19 formas reconhecidas de osteogênese imperfeita, designadas como tipo I até tipo XIX. Vários tipos são diferenciados pelos seus sinais e sintomas, embora suas características se sobreponham. Cada vez mais, causas genéticas são usadas para definir formas mais raras de osteogênese imperfeita. O tipo I (também conhecido como osteogênese imperfeita clássica não deformante com escleras azuis) é a forma mais leve de osteogênese imperfeita. O tipo II (também conhecido como osteogênese imperfeita letal perinatal) é a mais grave. Outros tipos desta condição, incluindo os tipos III (osteogênese imperfeita progressivamente deformante) e IV (osteogênese imperfeita variável comum com escleras normais), apresentam sinais e sintomas que ficam em algum ponto entre esses dois extremos.

As formas mais leves de osteogênese imperfeita, incluindo o tipo I, são caracterizadas por fraturas ósseas durante a infância e adolescência que frequentemente resultam de trauma menor, como quedas ao aprender a andar. As fraturas ocorrem com menos frequência na idade adulta. Pessoas com formas leves da condição tipicamente apresentam uma tonalidade azul ou cinza na parte do olho que normalmente é branca (a esclera) e cerca de metade desenvolve perda auditiva na idade adulta. Ao contrário de indivíduos mais gravemente afetados, pessoas com tipo I geralmente têm altura normal ou quase normal.

Outros tipos de osteogênese imperfeita são mais graves, causando fraturas ósseas frequentes que estão presentes ao nascer e resultam de pouco ou nenhum trauma. Características adicionais desses tipos podem incluir escleras azuis nos olhos, baixa estatura, curvatura da coluna vertebral (escoliose), deformidades articulares (contraturas), perda auditiva, problemas respiratórios e um distúrbio do desenvolvimento dentário chamado dentinogênese imperfeita. A mobilidade pode ser reduzida nas pessoas afetadas, e algumas podem usar um andador ou cadeira de rodas. As formas mais graves de osteogênese imperfeita, particularmente o tipo II, podem incluir uma caixa torácica anormalmente pequena e frágil e pulmões subdesenvolvidos. Bebês com essas anomalias podem ter problemas respiratórios que ameaçam a vida e podem morrer pouco depois do nascimento.

Fonte: MedlinePlus Genetics (NLM/NIH), traduzido
📋
Informacoes curadas por IA — podem conter imprecisoes

A osteogênese imperfeita (OI) compreende um grupo heterogêneo de doenças genéticas caracterizadas por aumento da fragilidade óssea, baixa massa óssea e suscetibilidade a fraturas ósseas com gravidade variável.

Pesquisas ativas
26 ensaios
84 total registrados no ClinicalTrials.gov
Publicações científicas
6.360 artigos
Último publicado: 2026 Apr 15
Medicamentos
8 com registro
NATIFA, SANDRENA, ESTRADIOL+ACETATO DE NORETISTERONA

Tem tratamento?

✓ 8 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
NATIFASANDRENAESTRADIOL+ACETATO DE NORETISTERONASYSTEN SEQUISUPREMANATIFA PROSYSTENESTALIS
Mais 10 moléculas em estudo para esta doença.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
8.06
Worldwide
Início
All ages
🏥
SUS: Cobertura completaScore: 65%
5 procedimentos SIGTAPCentros em: PA, PR, SC, RS, ES +10CID-10: Q78.0
🇧🇷Dados SUS / DATASUS
EXAMES E PROCEDIMENTOS RELACIONADOS (5)
•
Cariótipo — bandas G, Q ou R
•
Pesquisa de microdeleções/microduplicações por FISH
•
Sequenciamento completo do exoma (WES)
•
Dosagem de alfa-fetoproteína
•
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
110 sintomas
👁️
Olhos
45 sintomas
😀
Face
45 sintomas
🧠
Neurológico
40 sintomas
🧬
Pele e cabelo
36 sintomas
❤️
Coração
27 sintomas

+ 233 sintomas em outras categorias

Características mais comuns

90%prev.
Pectus carinatum
Muito frequente (99-80%)
90%prev.
Retardo do crescimento intrauterino
Muito frequente (99-80%)
90%prev.
Morfologia anormal da costela
Muito frequente (99-80%)
90%prev.
Costelas finas
Muito frequente (99-80%)
90%prev.
Anormalidade do esmalte dentário
Muito frequente (99-80%)
90%prev.
Deficiência auditiva
Muito frequente (99-80%)
637sintomas
Muito frequente (19)
Frequente (39)
Ocasional (33)
Muito raro (22)
Sem dados (524)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 637 características clínicas mais associadas, ordenadas por frequência.

Muito frequente (99-80%)90%
Retardo do crescimento intrauterinoIntrauterine growth retardation
Muito frequente (99-80%)90%
Morfologia anormal da costelaAbnormal rib morphology
Muito frequente (99-80%)90%
Muito frequente (99-80%)90%
Anormalidade do esmalte dentárioAbnormality of dental enamel
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico6.360PubMed
Últimos 10 anos200publicações
Pico2025124 papers
Linha do tempo
2026Hoje · 2026🧪 1991Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

41 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, X-linked recessive.

Curadoria gene-doença

fontes oficiais
COL1A1 COL1A2KIF5BFKBP10
COL1A1
SERPINF1Pigment epithelium-derived factorDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Osteogenesis imperfecta 6

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI6 is a severe, autosomal recessive form compatible with OI type III in the Sillence classification.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
776.6 TPM
Cervix Ectocervix
744.0 TPM
Fallopian Tube
733.7 TPM
Tecido adiposo
574.2 TPM
Mama
490.6 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 6osteogenesis imperfecta type 4osteogenesis imperfecta type 3
HGNC:8824UniProt:P36955
PLS3Plastin-3Candidate gene tested inAltamente restrito
MECANISMO DE DOENÇA

Osteoporosis

A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
752.5 TPM
Artéria tibial
580.0 TPM
Artéria coronária
423.3 TPM
Pulmão
213.0 TPM
Útero
212.9 TPM
OUTRAS DOENÇAS (2)
hernia, anterior diaphragmaticX-linked osteoporosis with fractures
HGNC:9091UniProt:P13797
WNT3AProtein Wnt-3aCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
WNT ligand biogenesis and trafficking
EXPRESSÃO TECIDUAL(Tecido-específico)
Pulmão
7.4 TPM
Skin Sun Exposed Lower leg
3.2 TPM
Skin Not Sun Exposed Suprapubic
2.8 TPM
Próstata
2.6 TPM
Esôfago - Mucosa
1.6 TPM
OUTRAS DOENÇAS (1)
idiopathic juvenile osteoporosis
HGNC:15983UniProt:P56704
DKK1Dickkopf-related protein 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by WNT ligand antagonists
EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
852.9 TPM
Cervix Endocervix
17.5 TPM
Tecido adiposo
15.3 TPM
Bladder
15.0 TPM
Skin Sun Exposed Lower leg
11.6 TPM
OUTRAS DOENÇAS (2)
idiopathic juvenile osteoporosisChiari malformation type I
HGNC:2891UniProt:O94907
POLR3ADNA-directed RNA polymerase III subunit RPC1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Cytosolic sensors of pathogen-associated DNA
MECANISMO DE DOENÇA

Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism

An autosomal recessive neurodegenerative disorder characterized by childhood onset of progressive motor decline manifest as spasticity, ataxia, tremor, and cerebellar signs, as well as mild cognitive regression. Other features may include hypodontia or oligodontia and hypogonadotropic hypogonadism. There is considerable inter- and intrafamilial variability.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
19.6 TPM
Cerebelo
18.6 TPM
Pituitária
15.8 TPM
Fibroblastos
14.5 TPM
Linfócitos
12.7 TPM
OUTRAS DOENÇAS (7)
leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadismWiedemann-Rautenstrauch syndrometremor-ataxia-central hypomyelination syndromeodontoleukodystrophy
HGNC:30074UniProt:O14802
KDELR2ER lumen protein-retaining receptor 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
COPI-mediated anterograde transport
MECANISMO DE DOENÇA

Osteogenesis imperfecta 21

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI21 is a progressively deforming form characterized by multiple fractures appearing at birth or early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
441.6 TPM
Aorta
226.8 TPM
Artéria coronária
187.1 TPM
Cervix Ectocervix
176.1 TPM
Útero
166.0 TPM
OUTRAS DOENÇAS (1)
osteogenesis imperfecta, type 21
HGNC:HGNC:6305UniProt:P33947
TMEM38BTrimeric intracellular cation channel type BDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Osteogenesis imperfecta 14

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI14 is characterized by variable degrees of severity of multiple fractures and osteopenia, with normal teeth, sclerae, and hearing. Fractures first occur prenatally or by age 6 years.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
27.1 TPM
Artéria tibial
24.2 TPM
Testículo
20.8 TPM
Tireoide
12.3 TPM
Cervix Endocervix
9.7 TPM
OUTRAS DOENÇAS (2)
osteogenesis imperfecta type 14osteogenesis imperfecta type 4
HGNC:25535UniProt:Q9NVV0
IFITM5Interferon-induced transmembrane protein 5Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Osteogenesis imperfecta 5

An autosomal dominant form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI5 patients manifest moderate to severe bone fragility, calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pâncreas
2.6 TPM
Pulmão
0.7 TPM
Rim - Medula
0.6 TPM
Sangue
0.4 TPM
Intestino delgado
0.4 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
osteogenesis imperfecta type 5
HGNC:16644UniProt:A6NNB3
SGMS2Phosphatidylcholine:ceramide cholinephosphotransferase 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Sphingolipid de novo biosynthesis
MECANISMO DE DOENÇA

Calvarial doughnut lesions with bone fragility

A rare autosomal dominant bone disease characterized by low bone density, distinctive X-ray translucencies of the skull, multiple fractures, elevated serum alkaline phosphatase, and dental caries. Patients present with childhood onset of primary osteoporosis and typical sclerotic doughnut-shaped lesions in the cranial bones.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
22.3 TPM
Fibroblastos
18.3 TPM
Pulmão
13.4 TPM
Tireoide
13.1 TPM
Cólon sigmoide
12.8 TPM
OUTRAS DOENÇAS (1)
calvarial doughnut lesions-bone fragility syndrome
HGNC:HGNC:28395UniProt:Q8NHU3
PLOD2Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Bruck syndrome 2

An autosomal recessive disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. It is distinguished from osteogenesis imperfecta by the absence of hearing loss and dentinogenesis imperfecta, and by the presence of clubfoot and congenital joint limitations.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
252.2 TPM
Tireoide
58.7 TPM
Aorta
56.4 TPM
Adipose Visceral Omentum
43.2 TPM
Artéria tibial
43.1 TPM
OUTRAS DOENÇAS (2)
Bruck syndrome 2Bruck syndrome
HGNC:9082UniProt:O00469
PYCR1Pyrroline-5-carboxylate reductase 1, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Glutamate and glutamine metabolism
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2B

A disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, a general connective tissue weakness, and varying degrees of growth and developmental delay and neurological abnormalities. Patients do not manifest metabolic abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
80.3 TPM
Linfócitos
66.8 TPM
Glândula salivar
38.9 TPM
Pâncreas
38.5 TPM
Estômago
25.9 TPM
OUTRAS DOENÇAS (3)
PYCR1-related de Barsy syndromeautosomal recessive cutis laxa type 2Bgeroderma osteodysplastica
HGNC:9721UniProt:P32322
ANO5Anoctamin-5Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Induction of Cell-Cell FusionStimuli-sensing channels
MECANISMO DE DOENÇA

Gnathodiaphyseal dysplasia

Rare skeletal syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbone. Patients experience frequent bone fractures caused by trivial accidents in childhood; however the fractures heal normally without bone deformity. The jaw lesions replace the tooth-bearing segments of the maxilla and mandible with fibrous connective tissues, including various amounts of cementum-like calcified mass, sometimes causing facial deformities. Patients also have a propensity for jaw infection and often suffer from purulent osteomyelitis-like symptoms, such as swelling of and pus discharge from the gums, mobility of the teeth, insufficient healing after tooth extraction and exposure of the lesions into the oral cavity.

OUTRAS DOENÇAS (6)
autosomal recessive limb-girdle muscular dystrophy type 2Lgnathodiaphyseal dysplasiaautosomal recessive limb-girdle muscular dystrophyMiyoshi muscular dystrophy 3
HGNC:27337UniProt:Q75V66
GORABRAB6-interacting golginDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Geroderma osteodysplasticum

A rare autosomal recessive disorder characterized by lax, wrinkled skin, joint laxity and a typical face with a prematurely aged appearance. Skeletal signs include severe osteoporosis leading to frequent fractures, malar and mandibular hypoplasia and a variable degree of growth retardation.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
17.6 TPM
Cervix Ectocervix
15.7 TPM
Fibroblastos
14.6 TPM
Ovário
14.3 TPM
Tecido adiposo
13.0 TPM
OUTRAS DOENÇAS (1)
geroderma osteodysplastica
HGNC:25676UniProt:Q5T7V8
XYLT2Xylosyltransferase 2Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Glycosaminoglycan-protein linkage region biosynthesis
MECANISMO DE DOENÇA

Spondyloocular syndrome

A syndrome characterized by cataract, loss of vision due to retinal detachment, facial dysmorphism, facial hypotonia, normal height with disproportional short trunk, osteoporosis, immobile spine with thoracic kyphosis and reduced lumbal lordosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Estômago
113.7 TPM
Testículo
46.3 TPM
Ovário
29.4 TPM
Próstata
29.3 TPM
Cervix Endocervix
28.1 TPM
OUTRAS DOENÇAS (2)
spondylo-ocular syndromeautosomal recessive inherited pseudoxanthoma elasticum
HGNC:15517UniProt:Q9H1B5
NBASNBAS subunit of NRZ tethering complexDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
COPI-dependent Golgi-to-ER retrograde traffic
MECANISMO DE DOENÇA

Short stature, optic nerve atrophy, and Pelger-Huet anomaly

An autosomal recessive syndrome characterized by severe postnatal growth retardation, facial dysmorphism with senile face, small hands and feet, normal intelligence, abnormal nuclear shape in neutrophil granulocytes (Pelger-Huet anomaly), and optic atrophy with loss of visual acuity and color vision.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
28.8 TPM
Fibroblastos
23.7 TPM
Ovário
20.6 TPM
Nervo tibial
20.5 TPM
Útero
19.9 TPM
OUTRAS DOENÇAS (3)
infantile liver failure syndrome 2short stature-optic atrophy-Pelger-Huët anomaly syndromeinfantile liver failure
HGNC:15625UniProt:A2RRP1
COL1A2Collagen alpha-2(I) chainDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresECM proteoglycansFibronectin matrix formation
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, arthrochalasia type, 2

A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSARTH2 is an autosomal dominant condition characterized by frequent congenital hip dislocation and extreme joint laxity with recurrent joint subluxations and minimal skin involvement.

OUTRAS DOENÇAS (11)
combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2Ehlers-Danlos syndrome, arthrochalasia type, 2osteogenesis imperfecta type 2osteogenesis imperfecta type 4
HGNC:2198UniProt:P08123
IFIH1Interferon-induced helicase C domain-containing protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (10)
DDX58/IFIH1-mediated induction of interferon-alpha/betaNegative regulators of DDX58/IFIH1 signalingTRAF3-dependent IRF activation pathwaySARS-CoV-2 activates/modulates innate and adaptive immune responsesOvarian tumor domain proteases
MECANISMO DE DOENÇA

Type 1 diabetes mellitus 19

A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
87.0 TPM
Baço
15.9 TPM
Pulmão
13.4 TPM
Nervo tibial
11.7 TPM
Útero
11.1 TPM
OUTRAS DOENÇAS (5)
immunodeficiency 95Singleton-Merten syndrome 1Aicardi-Goutieres syndrome 7Singleton-Merten dysplasia
HGNC:18873UniProt:Q9BYX4
MESDLRP chaperone MESDDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Osteogenesis imperfecta 20

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI20 is a progressive deforming form characterized by osteopenia, skeletal deformity, healed fractures, and newly-acquired fractures. Death due to respiratory failure can occur in some patients.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
osteogenesis imperfecta, type 20osteogenesis imperfecta type 2
HGNC:13520UniProt:Q14696
TENT5ATerminal nucleotidyltransferase 5ADisease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Osteogenesis imperfecta 18

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI18 is a severe form characterized by congenital bowing of the lower limb, wormian bones, blue sclerae, vertebral collapses and multiple fractures in the first years of life.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
osteogenesis imperfecta, type 18osteogenesis imperfecta type 3
HGNC:18345UniProt:Q96IP4
BMP1Bone morphogenetic protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
Degradation of the extracellular matrixCollagen biosynthesis and modifying enzymesCrosslinking of collagen fibrilsAnchoring fibril formation
MECANISMO DE DOENÇA

Osteogenesis imperfecta 13

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI13 is characterized by normal teeth, faint blue sclerae, severe growth deficiency, severe bone deformity, and recurrent fractures affecting both upper and lower limbs.

OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 13osteogenesis imperfecta type 3high bone mass osteogenesis imperfecta
HGNC:1067UniProt:P13497
FKBP10Peptidyl-prolyl cis-trans isomerase FKBP10Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Osteogenesis imperfecta 11

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
536.7 TPM
Aorta
242.2 TPM
Cervix Ectocervix
181.9 TPM
Cervix Endocervix
176.4 TPM
Artéria coronária
163.1 TPM
OUTRAS DOENÇAS (6)
osteogenesis imperfecta type 11Bruck syndrome 1arthrogryposis-like syndromeosteogenesis imperfecta type 4
HGNC:18169UniProt:Q96AY3
NHERF1Na(+)/H(+) exchange regulatory cofactor NHE-RF1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Nephrolithiasis/osteoporosis, hypophosphatemic, 2

A disease characterized by decreased renal phosphate absorption, renal phosphate wasting, hypophosphatemia, hyperphosphaturia, hypercalciuria, nephrolithiasis and osteoporosis.

OUTRAS DOENÇAS (2)
hypophosphatemic nephrolithiasis/osteoporosis 2obsolete dominant hypophosphatemia with nephrolithiasis or osteoporosis
HGNC:11075UniProt:O14745
SEC24DProtein transport protein Sec24DDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (6)
Antigen Presentation: Folding, assembly and peptide loading of class I MHCSARS-CoV-2 activates/modulates innate and adaptive immune responsesMHC class II antigen presentationRegulation of cholesterol biosynthesis by SREBP (SREBF)COPII-mediated vesicle transport
MECANISMO DE DOENÇA

Cole-Carpenter syndrome 2

A form of Cole-Carpenter syndrome, a disorder characterized by features of osteogenesis imperfecta such as bone deformities and severe bone fragility with frequent fractures, in association with craniosynostosis, ocular proptosis, hydrocephalus, growth failure and distinctive facial features. Craniofacial findings include marked frontal bossing, midface hypoplasia, and micrognathia. Despite the craniosynostosis and hydrocephalus, intellectual development is normal. CLCRP2 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
89.5 TPM
Aorta
51.3 TPM
Linfócitos
42.0 TPM
Artéria coronária
41.7 TPM
Artéria tibial
40.2 TPM
OUTRAS DOENÇAS (3)
Cole-Carpenter syndrome 2osteogenesis imperfecta type 1Cole-Carpenter syndrome
HGNC:10706UniProt:O94855
P4HBProtein disulfide-isomeraseDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (10)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)Detoxification of Reactive Oxygen SpeciesVLDL assemblyChylomicron assembly
MECANISMO DE DOENÇA

Cole-Carpenter syndrome 1

A form of Cole-Carpenter syndrome, a disorder characterized by features of osteogenesis imperfecta such as bone deformities and severe bone fragility with frequent fractures, in association with craniosynostosis, ocular proptosis, hydrocephalus, growth failure and distinctive facial features. Craniofacial findings include marked frontal bossing, midface hypoplasia, and micrognathia. Despite the craniosynostosis and hydrocephalus, intellectual development is normal. CLCRP1 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
1252.5 TPM
Pâncreas
960.6 TPM
Glândula salivar
583.6 TPM
Esôfago - Mucosa
558.8 TPM
Fígado
511.2 TPM
OUTRAS DOENÇAS (3)
Cole-Carpenter syndrome 1osteogenesis imperfecta type 1Cole-Carpenter syndrome
HGNC:8548UniProt:P07237
B4GALT7Beta-1,4-galactosyltransferase 7Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Glycosaminoglycan-protein linkage region biosynthesis
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, spondylodysplastic type, 1

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSSPD1 is an autosomal recessive form characterized by short stature, developmental anomalies of the forearm bones and elbow, and bowing of extremities, in addition to the classic features of Ehlers-Danlos syndrome.

OUTRAS DOENÇAS (2)
Ehlers-Danlos syndrome, spondylodysplastic type, 1Ehlers-Danlos syndrome, spondylodysplastic type
HGNC:930UniProt:Q9UBV7
SERPINH1Serpin H1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 10

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI10 is an autosomal recessive form characterized by multiple bone deformities and fractures, generalized osteopenia, dentinogenesis imperfecta, and blue sclerae.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
500.1 TPM
Cervix Endocervix
142.7 TPM
Aorta
134.4 TPM
Adipose Visceral Omentum
131.0 TPM
Pulmão
128.4 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 10osteogenesis imperfecta type 3preterm premature rupture of the membranes
HGNC:1546UniProt:P50454
ATP6V0A2V-type proton ATPase 116 kDa subunit a 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Insulin receptor recyclingTransferrin endocytosis and recyclingIon channel transport
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2A

A disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, a general connective tissue weakness, and varying degrees of growth and developmental delay and neurological abnormalities. Some affected individuals develop seizures and mental deterioration later in life, whereas the skin phenotype tends to become milder with age. At the molecular level, an abnormal glycosylation of serum proteins is observed in many cases.

OUTRAS DOENÇAS (3)
wrinkly skin syndromeautosomal recessive cutis laxa type 2Aautosomal recessive cutis laxa type 2, classic type
HGNC:18481UniProt:Q9Y487
LRP5Low-density lipoprotein receptor-related protein 5Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by WNT ligand antagonists
MECANISMO DE DOENÇA

Vitreoretinopathy, exudative 1

An autosomal dominant disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. In many ways the disease resembles retinopathy of prematurity but there is no evidence of prematurity or small birth weight in the patient history.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
83.2 TPM
Artéria tibial
67.8 TPM
Glândula salivar
64.2 TPM
Útero
56.7 TPM
Tireoide
51.4 TPM
OUTRAS DOENÇAS (12)
polycystic liver disease 4 with or without kidney cystsobsolete bone mineral density quantitative trait locus 1autosomal dominant osteosclerosis, Worth typeosteoporosis-pseudoglioma syndrome
HGNC:6697UniProt:O75197
PHLDB1Pleckstrin homology-like domain family B member 1Disease-causing germline mutation(s) inRestrito
MECANISMO DE DOENÇA

Osteogenesis imperfecta 23

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI23 is a mild form characterized by osteopenia with or without recurrent fractures, platyspondyly, short and bowed long bones, and widened metaphyses. Platyspondyly and metaphyseal enlargement is present in infancy but resolve in middle childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
159.9 TPM
Tecido adiposo
122.2 TPM
Cervix Ectocervix
115.0 TPM
Cervix Endocervix
104.9 TPM
Útero
99.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
osteogenesis imperfecta, type 23
HGNC:HGNC:23697UniProt:Q86UU1
SP7Transcription factor Sp7Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
RUNX2 regulates osteoblast differentiation
MECANISMO DE DOENÇA

Osteogenesis imperfecta 12

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI12 is an autosomal recessive form characterized by recurrent fractures, mild bone deformations, delayed teeth eruption, no dentinogenesis imperfecta, normal hearing, and white sclerae.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.6 TPM
Tireoide
0.4 TPM
Brain Spinal cord cervical c-1
0.4 TPM
Nervo tibial
0.3 TPM
Córtex cerebral
0.3 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 12craniodiaphyseal dysplasiaosteogenesis imperfecta type 4
HGNC:17321UniProt:Q8TDD2
PPIBPeptidyl-prolyl cis-trans isomerase BDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 9

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI9 is a severe autosomal recessive form of the disorder.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
1305.6 TPM
Tireoide
710.5 TPM
Cervix Endocervix
659.6 TPM
Aorta
641.6 TPM
Ovário
618.5 TPM
OUTRAS DOENÇAS (4)
osteogenesis imperfecta type 9osteogenesis imperfecta type 2osteogenesis imperfecta type 3osteogenesis imperfecta type 4
HGNC:9255UniProt:P23284
COL1A1Collagen alpha-1(I) chainDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresECM proteoglycansFibronectin matrix formation
MECANISMO DE DOENÇA

Caffey disease

An autosomal dominant disorder characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age.

OUTRAS DOENÇAS (13)
Ehlers-Danlos syndrome type 7Aosteogenesis imperfecta type 3osteogenesis imperfecta type 4osteogenesis imperfecta type 1
HGNC:2197UniProt:P02452
SPARCSPARCDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Nuclear signaling by ERBB4
MECANISMO DE DOENÇA

Osteogenesis imperfecta 17

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
2798.5 TPM
Nervo tibial
2365.4 TPM
Artéria coronária
1738.1 TPM
Fibroblastos
1597.8 TPM
Artéria tibial
1508.4 TPM
OUTRAS DOENÇAS (2)
osteogenesis imperfecta type 17osteogenesis imperfecta type 4
HGNC:11219UniProt:P09486
CREB3L1Cyclic AMP-responsive element-binding protein 3-like protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
CREB3 factors activate genes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 16

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI16 is a severe form.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
103.5 TPM
Glândula salivar
83.5 TPM
Próstata
60.5 TPM
Estômago
54.5 TPM
Cervix Ectocervix
53.4 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 16myxofibrosarcomaosteogenesis imperfecta type 3
HGNC:18856UniProt:Q96BA8
P3H1Prolyl 3-hydroxylase 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 8

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI8 is characterized by disproportionate short stature, shortening of the long bones, white sclerae, a round face and a short barrel-shaped chest.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
107.0 TPM
Pituitária
59.0 TPM
Nervo tibial
57.0 TPM
Cervix Ectocervix
54.8 TPM
Cervix Endocervix
50.5 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 8osteogenesis imperfecta type 2osteogenesis imperfecta type 3
HGNC:19316UniProt:Q32P28
CRTAPCartilage-associated proteinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 7

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI7 is an autosomal recessive, severe form. Multiple fractures are present at birth and patients have short stature, short humeri and femora, coxa vara, and white sclera. Dentinogenesis imperfecta is absent. Death can occur in the perinatal period due to secondary respiratory insufficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
262.7 TPM
Aorta
241.2 TPM
Artéria tibial
216.4 TPM
Cervix Endocervix
190.5 TPM
Artéria coronária
183.7 TPM
OUTRAS DOENÇAS (5)
osteogenesis imperfecta type 7osteogenesis imperfecta type 4osteogenesis imperfecta type 3Cole-Carpenter syndrome
HGNC:2379UniProt:O75718
SLC34A1Sodium-dependent phosphate transport protein 2ADisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Surfactant metabolismType II Na+/Pi cotransporters
MECANISMO DE DOENÇA

Nephrolithiasis/osteoporosis, hypophosphatemic, 1

A disease characterized by decreased renal phosphate absorption, renal phosphate wasting, hypophosphatemia, hyperphosphaturia, hypercalciuria, nephrolithiasis and osteoporosis.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
35.5 TPM
Rim - Medula
19.9 TPM
Fígado
0.6 TPM
Esôfago - Mucosa
0.3 TPM
Skin Not Sun Exposed Suprapubic
0.2 TPM
OUTRAS DOENÇAS (7)
hypophosphatemic nephrolithiasis/osteoporosis 1hypercalcemia, infantile, 2Fanconi renotubular syndrome 2obsolete dominant hypophosphatemia with nephrolithiasis or osteoporosis
HGNC:11019UniProt:Q06495
RIGIAntiviral innate immune response receptor RIG-IDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (10)
SARS-CoV-2 activates/modulates innate and adaptive immune responsesDDX58/IFIH1-mediated induction of interferon-alpha/betaModulation of host responses by IFN-stimulated genesNegative regulators of DDX58/IFIH1 signalingUb-specific processing proteases
MECANISMO DE DOENÇA

Singleton-Merten syndrome 2

A form of Singleton-Merten syndrome, an autosomal dominant disorder characterized by marked aortic calcification, dental anomalies, osteopenia, acro-osteolysis, and to a lesser extent glaucoma, psoriasis, muscle weakness, and joint laxity. Additional clinical manifestations include particular facial characteristics and abnormal joint and muscle ligaments. SGMRT2 is an atypical form characterized by variable expression of glaucoma, aortic calcification, and skeletal abnormalities, without dental anomalies.

OUTRAS DOENÇAS (2)
Singleton-Merten syndrome 2Singleton-Merten dysplasia
HGNC:19102UniProt:O95786
CCDC134Coiled-coil domain-containing protein 134Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Osteogenesis imperfecta 22

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI22 is a severe form of the disease.

OUTRAS DOENÇAS (1)
osteogenesis imperfecta, IIA 22
HGNC:HGNC:26185UniProt:Q9H6E4
WNT1Proto-oncogene Wnt-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
WNT ligand biogenesis and trafficking
MECANISMO DE DOENÇA

Osteoporosis

A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Nucleus accumbens basal ganglia
4.4 TPM
Córtex cerebral
2.2 TPM
Testículo
1.9 TPM
Brain Caudate basal ganglia
1.4 TPM
Brain Frontal Cortex BA9
1.3 TPM
OUTRAS DOENÇAS (4)
osteogenesis imperfecta type 15idiopathic juvenile osteoporosisosteogenesis imperfecta type 3osteogenesis imperfecta type 4
HGNC:12774UniProt:P04628
MBTPS2Membrane-bound transcription factor site-2 proteaseDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
CREB3 factors activate genesATF6 (ATF6-alpha) activates chaperonesATF6B (ATF6-beta) activates chaperonesRegulation of cholesterol biosynthesis by SREBP (SREBF)
MECANISMO DE DOENÇA

IFAP syndrome 1, with or without Bresheck syndrome

An X-linked syndrome characterized by a peculiar triad of follicular ichthyosis, total or subtotal atrichia, and photophobia of varying degree. Histopathologically, the epidermal granular layer is generally well-preserved or thickened at the infundibulum. Hair follicles are poorly developed and tend to be surrounded by an inflammatory infiltrate. A subgroup of patients is described with lamellar rather than follicular ichthyosis. Non-consistent features may include growth and psychomotor retardation, aganglionic megacolon, seizures and nail dystrophy.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
16.6 TPM
Cérebro - Hemisfério cerebelar
10.1 TPM
Ovário
9.0 TPM
Útero
8.1 TPM
Cervix Endocervix
8.1 TPM
OUTRAS DOENÇAS (11)
osteogenesis imperfecta, type 19keratosis follicularis spinulosa decalvans, X-linkedOlmsted syndrome, X-linkedIFAP syndrome 1, with or without BRESHECK syndrome
HGNC:15455UniProt:O43462

Medicamentos e terapias

RALOXIFENE HYDROCHLORIDEPhase 4

Mecanismo: Estrogen receptor beta modulator

ESTROGENS, CONJUGATEDPhase 4

Mecanismo: Estrogen receptor agonist

DENOSUMABPhase 4

Mecanismo: Tumor necrosis factor ligand superfamily member 11 inhibitor

ESTRADIOLPhase 4

Mecanismo: Estrogen receptor alpha agonist

RISEDRONATE SODIUMPhase 4

Mecanismo: Farnesyl diphosphate synthase inhibitor

ROMOSOZUMABPhase 4

Mecanismo: Sclerostin inhibitor

IBANDRONATE SODIUMPhase 4

Mecanismo: Farnesyl diphosphate synthase inhibitor

CALCITONIN SALMONPhase 4

Mecanismo: Calcitonin receptor agonist

ZOLEDRONIC ACIDPhase 4

Mecanismo: Farnesyl diphosphate synthase inhibitor

TERIPARATIDEPhase 4

Mecanismo: Parathyroid hormone receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

425 variantes patogênicas registradas no ClinVar.

🧬 SERPINF1: NM_002615.7(SERPINF1):c.787-1G>T ()
🧬 SERPINF1: NM_002615.7(SERPINF1):c.358G>T (p.Gly120Cys) ()
🧬 SERPINF1: GRCh38/hg38 17p13.3(chr17:240638-1939562)x1 ()
🧬 SERPINF1: NM_002615.7(SERPINF1):c.262GCCCTCTCG[1] (p.88ALS[1]) ()
🧬 SERPINF1: GRCh37/hg19 17p13.3(chr17:257557-1791653)x4 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 7.473 variantes classificadas pelo ClinVar.

1121
1495
4857
Patogênica (15.0%)
VUS (20.0%)
Benigna (65.0%)
VARIANTES MAIS SIGNIFICATIVAS
COL1A1: NM_000088.4(COL1A1):c.289_290dup (p.Asp97fs) [Pathogenic]
CRTAP: NM_006371.5(CRTAP):c.14_15dup (p.Arg6fs) [Pathogenic]
COL1A1: NM_000088.4(COL1A1):c.1060G>T (p.Glu354Ter) [Pathogenic]
P3H1: NM_022356.4(P3H1):c.1070G>A (p.Gly357Asp) [Uncertain significance]
COL1A1: NM_000088.4(COL1A1):c.4134C>G (p.Asp1378Glu) [Uncertain significance]

Vias biológicas (Reactome)

106 vias biológicas associadas aos genes desta condição.

TCF dependent signaling in response to WNT WNT ligand biogenesis and trafficking Class B/2 (Secretin family receptors) Negative regulation of TCF-dependent signaling by WNT ligand antagonists Disassembly of the destruction complex and recruitment of AXIN to the membrane Regulation of FZD by ubiquitination Signaling by RNF43 mutants Formation of paraxial mesoderm Formation of the posterior neural plate Specification of the neural plate border Transcriptional and post-translational regulation of MITF-M expression and activity Signaling by LRP5 mutants Cytosolic sensors of pathogen-associated DNA RNA Polymerase III Chain Elongation RNA Polymerase III Transcription Termination RNA Polymerase III Abortive And Retractive Initiation RNA Polymerase III Transcription Initiation From Type 1 Promoter RNA Polymerase III Transcription Initiation From Type 2 Promoter RNA Polymerase III Transcription Initiation From Type 3 Promoter COPI-mediated anterograde transport COPI-dependent Golgi-to-ER retrograde traffic Sphingolipid de novo biosynthesis Collagen biosynthesis and modifying enzymes Glutamate and glutamine metabolism Stimuli-sensing channels Induction of Cell-Cell Fusion Glycosaminoglycan-protein linkage region biosynthesis GPVI-mediated activation cascade Collagen degradation Fibronectin matrix formation Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Assembly of collagen fibrils and other multimeric structures Cell surface interactions at the vascular wall Integrin cell surface interactions SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription Anchoring fibril formation Crosslinking of collagen fibrils Syndecan interactions Non-integrin membrane-ECM interactions ECM proteoglycans Scavenging by Class A Receptors GP1b-IX-V activation signalling Interleukin-4 and Interleukin-13 signaling Platelet Adhesion to exposed collagen Platelet Aggregation (Plug Formation) MET activates PTK2 signaling Collagen chain trimerization Enhanced cleavage of VWF variant by ADAMTS13 Enhanced binding of GP1BA variant to VWF multimer:collagen Defective VWF cleavage by ADAMTS13 variant Defective VWF binding to collagen type I Defective binding of VWF variant to GPIb:IX:V Developmental Lineage of Pancreatic Ductal Cells DDX58/IFIH1-mediated induction of interferon-alpha/beta Ub-specific processing proteases Ovarian tumor domain proteases TRAF3-dependent IRF activation pathway TRAF6 mediated IRF7 activation TRAF6 mediated NF-kB activation NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 Negative regulators of DDX58/IFIH1 signaling SARS-CoV-1 activates/modulates innate immune responses SARS-CoV-2 activates/modulates innate and adaptive immune responses Evasion by RSV of host interferon responses Modulation of host responses by IFN-stimulated genes Dengue virus activates/modulates innate and adaptive immune responses Degradation of the extracellular matrix HDL assembly Proline hydroxylases hydroxylate Polyprotein Regulation of cholesterol biosynthesis by SREBP (SREBF) COPII-mediated vesicle transport MHC class II antigen presentation Cargo concentration in the ER Antigen Presentation: Folding, assembly and peptide loading of class I MHC Insulin processing Detoxification of Reactive Oxygen Species Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Hedgehog ligand biogenesis VLDL assembly Post-translational protein phosphorylation Chylomicron assembly LDL remodeling Interleukin-12 signaling Interleukin-23 signaling Maturation of DENV proteins Defective B4GALT7 causes EDS, progeroid type ROS and RNS production in phagocytes Insulin receptor recycling Transferrin endocytosis and recycling Ion channel transport RUNX2 regulates osteoblast differentiation Platelet degranulation Nuclear signaling by ERBB4 Scavenging by Class H Receptors CREB3 factors activate genes Type II Na+/Pi cotransporters Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1) Surfactant metabolism ISG15 antiviral mechanism OAS antiviral response RSV-host interactions Transcriptional regulation of white adipocyte differentiation PCP/CE pathway ATF6 (ATF6-alpha) activates chaperones ATF6B (ATF6-beta) activates chaperones Assembly of active LPL and LIPC lipase complexes

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado16
3Fase 311
2Fase 214
1Fase 18
·Pré-clínico45
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 84 ensaios
✓ Aprovados — podem ser usados hoje
RALOXIFENE HYDROCHLORIDEESTROGENS, CONJUGATEDDENOSUMABESTRADIOLRISEDRONATE SODIUMROMOSOZUMABIBANDRONATE SODIUMCALCITONIN SALMONZOLEDRONIC ACIDTERIPARATIDE
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Osteogenesis imperfecta

Centros de Referência SUS

24 centros habilitados pelo SUS para Osteogenesis imperfecta

Centros para Osteogenesis imperfecta

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 15 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

11 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

84 ensaios clínicos encontrados, 26 ativos.

Distribuição por fase
NCT05559801 · Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)Em breve
PHASE1, PHASE2
NCT07666269 · Morphology in Oral Rare Syndromes & Artificial Intelligence …Em breve
NA🇫🇷 França
NCT07594639 · GRACE II (General Retrospective Analysis of Commercial Exper…Em breve
🇧🇪 Bélgica
NCT07173010 · Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum…Em breve
NCT06874166 · Social Cognition in Dystrophinopathies and Neurodevelopmenta…Em breve
NCT05258019 · Site Preservation After Tooth ExtractionEm breve
NCT05768854 · Setrusumab vs Bisphosphonates in Pediatric Subjects With Ost…Ativo
PHASE3🇧🇷 Brasil · 🇨🇦 Canadá · 🇫🇷 França +4
NCT06636071 · Setrusumab in Pediatric Japanese Subjects With Osteogenesis …Ativo
PHASE3🇯🇵 Japão
NCT05972551 · Study to Evaluate Efficacy and Safety of Romosozumab Compare…Ativo
PHASE3🇦🇺 Austrália · 🇦🇹 Áustria · 🇧🇪 Bélgica +15
NCT04815564 · Clear Aligners for the Treatment of Dental Malocclusion in O…Ativo
NA🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT05317637 · Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708Ativo
🇺🇸 Estados Unidos
NCT05125809 · Setrusumab vs Placebo for Osteogenesis ImperfectaAtivo
PHASE2, PHASE3🇦🇺 Austrália · 🇨🇦 Canadá · 🇫🇷 França +8
NCT03706482 · Boost Brittle Bones Before BirthAtivo
PHASE1, PHASE2🇸🇪 Suécia
NCT02934451 · Dental Malocclusion and Craniofacial Development in OIAtivo
🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT02531087 · Urinary Biomarkers of OI PathobiologyAtivo
🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT06555536 · e-Health Care Method for Patients With Osteogenesis Imperfec…Concluído
NA🇧🇷 Brasil
NCT03841188 · Nutritional Interventional in Pediatric Patients With Osteog…Concluído
NA🇧🇷 Brasil
NCT05612139 · Post-market Observational Study on JTIN Telescopic Nail in O…Concluído
🇫🇷 França
NCT06397443 · Ready to Sail: Evaluating Sailing's Feasibility as Ergothera…Concluído
NA🇮🇹 Itália
NCT06086613 · A First-in-Human Study Evaluating AGA2115 in Adult Healthy V…Concluído
PHASE1🇺🇸 Estados Unidos
NCT06193642 · Increasing Knowledge on Osteogenesis Imperfecta by Collectin…Concluído
NA🇮🇹 Itália
NCT05321199 · Tranexamic Acid During Telescoping Nail Application In Osteo…Concluído
NA🇪🇬 Egito
NCT04844697 · Resilience and Coping in a Rare Skeletal Disease Population …Concluído
🇮🇹 Itália
NCT04545554 · Study to Evaluate Romosozumab in Children and Adolescents Wi…Concluído
PHASE1🇦🇹 Áustria · 🇩🇪 Alemanha · Greece +5
NCT04169568 · Osteogenesis Imperfecta Blood Pressure StudyConcluído
🇺🇸 Estados Unidos
NCT04119388 · Evaluation of the Benefits of Adaptive Physical Activity in …Concluído
NA🇫🇷 França
NCT04009733 · Epigenetic Regulation of Osteogenesis Imperfecta Severity : …Concluído
NA🇫🇷 França
NCT04282408 · Experimental Evaluation of Back Braces for the Treatment of …Concluído
NA🇮🇹 Itália
NCT03575221 · Natural History of the Collagen-Related Disorder Osteogenesi…Concluído
🇺🇸 Estados Unidos
NCT03064074 · Safety of Fresolimumab in the Treatment of Osteogenesis Impe…Concluído
PHASE1🇺🇸 Estados Unidos
NCT03118570 · A Study in Adult Patients With Type I, III or IV Osteogenesi…Concluído
PHASE2🇨🇦 Canadá · 🇩🇰 Dinamarca · 🇫🇷 França +2
NCT03072303 · Pregnancy in Osteogenesis Imperfecta (OI) RegistryConcluído
🇺🇸 Estados Unidos
NCT03208582 · Do Bisphosphonates Alter the Skeletal Response to Mechanical…Concluído
PHASE2🇬🇧 Reino Unido
NCT03735537 · Treatment of Osteogenesis Imperfecta With Parathyroid Hormon…Concluído
PHASE4🇮🇪 Irlanda · 🇬🇧 Reino Unido
NCT02793063 · Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Pr…Concluído
🇺🇸 Estados Unidos
NCT04231916 · High Resolution Thermal Imaging to Identify Vertebral Fractu…Concluído
NA
NCT03557567 · NGS Strategy Effectiveness in Molecular DiagnosisConcluído
NCT02172885 · Mesenchymal Stem Cell Based Therapy for the Treatment of Ost…Concluído
PHASE1🇪🇸 Espanha
NCT01799798 · Translational Therapy in Patients With Osteogenesis Imperfec…Concluído
PHASE2🇩🇪 Alemanha
NCT01713231 · Effect of High-Dose Vitamin D on Bone Density in Osteogenesi…Concluído
PHASE4🇨🇦 Canadá
NCT03029312 · Whole Body Vibration Training in Children With Osteogenesis …Concluído
NA🇬🇧 Reino Unido
NCT01417091 · Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in O…Concluído
PHASE2🇧🇪 Bélgica · 🇨🇦 Canadá · 🇩🇪 Alemanha +1
NCT01061099 · Repeated Infusions of Mesenchymal Stromal Cells in Children …Concluído
PHASE1🇺🇸 Estados Unidos
NCT00982124 · An Efficacy and Safety Trial of Intravenous Zoledronic Acid …Concluído
PHASE3🇨🇦 Canadá
NCT00655681 · Prevention of Post Operative Bone Loss in ChildrenConcluído
NA🇺🇸 Estados Unidos
NCT02303873 · Efficacy and Safety of Alendronate in Chinese Children or Ad…Concluído
PHASE4
NCT00131469 · Study of Teriparatide (FORTEO) to Treat Adults With Osteogen…Concluído
PHASE4🇺🇸 Estados Unidos
NCT00106028 · Safety and Efficacy of Risedronate in the Treatment of Osteo…Concluído
PHASE3🇦🇺 Austrália · 🇧🇪 Bélgica · 🇨🇱 Chile +10
NCT00131118 · Zoledronic Acid in Children (1 -17 Years) With Severe Osteog…Concluído
PHASE2🇺🇸 Estados Unidos
NCT00076830 · Evaluation and Treatment of Patients With Connective Tissue …Concluído
🇺🇸 Estados Unidos
NCT00187018 · Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta:…Concluído
NA🇺🇸 Estados Unidos
NCT00063479 · Bisphosphonate Treatment of Osteogenesis ImperfectaConcluído
PHASE2🇺🇸 Estados Unidos
NCT00005901 · Pamidronate to Treat Osteogenesis Imperfecta in ChildrenConcluído
PHASE3🇺🇸 Estados Unidos
NCT00159419 · Bisphosphonate Therapy for Osteogenesis ImperfectaConcluído
PHASE4
NCT00186914 · Stromal Therapy of Osteodysplasia After Allogeneic Bone Marr…Concluído
PHASE1🇺🇸 Estados Unidos
NCT00001594 · Evaluation and Intervention for the Effects of Osteogenesis …Concluído
🇺🇸 Estados Unidos
NCT00705120 · Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bo…Concluído
PHASE1🇺🇸 Estados Unidos
NCT00001305 · Growth Hormone Therapy in Osteogenesis ImperfectaConcluído
PHASE3🇺🇸 Estados Unidos
NCT06065111 · Study of Osteogenesis Imperfecta TendonUNKNOWN
🇧🇪 Bélgica
NCT05878548 · Management of Combined Fracture Neck of Femur and Femoral De…UNKNOWN
NA🇪🇬 Egito
NCT06010134 · Osteogenesis Imperfecta and BalanceUNKNOWN
NA🇪🇬 Egito
NCT06591546 · Telescoping Nail in Osteogenesis ImperfectaUNKNOWN
NA🇪🇬 Egito
NCT04694144 · Results of Telescoping Nail In OI; a Case SeriesUNKNOWN
🇪🇬 Egito
NCT04623606 · Boost to Brittle Bones - Stem Cell Transplantation for Treat…UNKNOWN
PHASE1, PHASE2🇮🇳 Índia
NCT02814591 · Development of a Non-invasive Assessment of Human Bone Quali…UNKNOWN
NCT02868294 · Preventive Fixation of Lower Limbs in Osteogenesis Imperfect…UNKNOWN
NA🇫🇷 França
NCT05231668 · Single Ascending Dose Study of SAR439459 in Adults With Oste…Encerrado
PHASE1🇦🇺 Austrália · 🇨🇦 Canadá · 🇫🇷 França +1
NCT05312697 · Long-term Extension Study of Setrusumab in Adults With Type …Encerrado
PHASE2🇺🇸 Estados Unidos
NCT03638128 · Open-label Extension of Study 20130173 of Denosumab in Child…Encerrado
PHASE3🇦🇺 Austrália · 🇧🇪 Bélgica · 🇨🇦 Canadá +9
NCT02352753 · Multicenter,Single-arm Study to Evaluate Efficacy, Safety, &…Encerrado
PHASE3🇦🇺 Austrália · 🇧🇪 Bélgica · Bulgaria +10
NCT02542540 · Effects of a Physical Rehabilitation Program Using the Ninte…Encerrado
NA🇫🇷 França
NCT01679080 · The Effect of Treatment With Teriparatide and Zoledronic Aci…Encerrado
PHASE2🇩🇰 Dinamarca
NCT03216486 · An Exploratory Study of BPS804 Treatment in Adult Patients W…Cancelado
PHASE2🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
2.471 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 2.471

#1

Mechanical characterization of Col1a1 +/- osteogenesis imperfecta bone revealed altered mechanical stiffness heterogeneity across scales.

Cell biomaterials2026 Feb 17

This study presents a novel integrated multiscale approach that combines whole-bone strain mapping, nanoscale mechanical testing, and compositional profiling to reveal how structural changes across scales impair bone quality in osteogenesis imperfecta (OI). OI is a genetic disorder caused by mutations in type I collagen that leads to fragile bones. Using femurs from male Col1a1+/- haploinsufficient OI (type I) mice, we examined how mechanics relate to structural and compositional changes. The results indicate that OI bone exhibits increased heterogeneity in mechanical properties and lacks the characteristic alternating soft and stiff lamellae that are critical for absorbing fracture energy in healthy bone. While previous studies have investigated OI biomechanics, few have integrated framework spanning organ-, tissue-, and nanoscale levels. Our results underscore the importance of restoring the hierarchical bone architecture and suggest a need for therapies that target bone quality, not just bone mass, to effectively mitigate fracture risk in OI.

#2

Addressing the unmet challenge of pain in rare bone diseases: new insights from the RUDY UK registry.

Orphanet journal of rare diseases2026 Jan 29

Pain is a common symptom in many rare bone disorders, often linked to depression and a substantial decline in quality of life. However, there is little information on the quality of the pain which may provide insights into pain mechanisms. This study aimed to describe and compare the frequency and characteristics of self-reported pain in adults with Fibrous Dysplasia of Bone/McCune-Albright Syndrome (FD/MAS), Osteogenesis Imperfecta (OI), and X-linked Hypophosphatemia (XLH). A cross-sectional study was conducted using the online UK RUDY registry. Adults with self -reported FD/MAS, OI, and XLH who completed the painDETECT questionnaire (PD-Q) were included. Pain prevalence and phenotypes were assessed using baseline PD-Q responses which were also mapped to a modified widespread pain index as a measure of generalized pain. Descriptive analyses were performed using R®. A total of 281 adults completed the baseline PD-Q (94 FD/MAS, 94 OI, and 93 XLH). Among these, 86% of patients currently experienced pain and 47% reported severe strongest pain in the past four weeks, with no significant differences between conditions. Pain prevalence and phenotype were similar across diseases, though pain sites differed. Neuropathic-like pain and female sex were significantly associated with poorer pain outcomes, including higher pain prevalence and intensity (p < 0.05). Generalized pain (18%) was significantly associated with moderate to severe anxiety (p = 0.03), depression (p < 0.001) and sleep impairment (p < 0.001). Despite distinct pathophysiological mechanisms, pain distribution appears similar across these bone diseases, suggesting a major role for non-skeletal factors. Generalized pain was frequent and associated with anxiety, depression, and sleep disturbances, suggesting nociplastic features maybe a significant driver of pain in adults with rare bone diseases. The online version contains supplementary material available at 10.1186/s13023-025-04167-4.

#3

A New Perspective on Osteogenesis Imperfecta: From Cellular Mechanisms to the Systemic Impact of Collagen Dysfunction.

International journal of molecular sciences2026 Jan 12

Osteogenesis imperfecta (OI) is a rare genetic disease caused by mutations in collagen type I, leading to defective protein folding and an impaired extracellular matrix structure and remodelling. Beyond skeletal fragility, these molecular defects trigger a network of intracellular stress responses with multiorgan implications: the accumulation of misfolded collagen can induce persistent endoplasmic reticulum stress, which can in turn compromise mitochondrial function and autophagy or lead to cell death activation, and it can even promote widespread redox imbalance and inflammation. The interplay between intracellular stress, widespread oxidative damage and inflammation not only underlies cellular dysfunction but also the multisystemic manifestations of osteogenesis imperfecta. Targeting these interconnected pathways may result in new insights for a better understanding of OI and possibly offer novel therapeutic strategies designed to restore proteostasis and improve cell homeostasis and overall patient outcomes, highlighting the need for an integrated understanding of the cellular and molecular mechanisms involved in the pathogenesis of this disease and their translation into patient-centred therapeutic interventions.

#4

Oral health-related quality of life in patients with osteogenesis imperfecta in Taiwan.

Journal of dental sciences2026 Jan

Osteogenesis imperfecta (OI) is a rare genetic disorder that affects bone and dental structures, often reducing oral health-related quality of life (OHRQoL). Maintaining OHRQoL in individuals with OI depends greatly on their dental conditions. Thus, this study identified key dental factors associated with OHRQoL in this population. Thirty-seven patients with OI participated in this cross-sectional study. Data were collected using structured questionnaires on sociodemographic characteristics, oral habits, self-perceived oral health, and OHRQoL. Clinical examinations were performed to evaluate dental status. Associations between dental variables and OHRQoL were analyzed using the Mann-Whitney U test and Kruskal-Wallis test. Multiple logistic regression analysis was used to identify the significant predictors of poor OHRQoL. Multiple logistic regression analysis revealed that the number of posterior functional tooth units (P-FTUs) was the only significant dental predictor of OHRQoL. A higher P-FTU count was significantly associated with better OHRQoL scores. An adequate number of P-FTUs is essential for maintaining OHRQoL in patients with OI. In addition to retaining natural teeth or fixed prostheses, ensuring proper distribution and functional occlusion is critical. Clinicians should prioritize treatment strategies that preserve posterior occlusion and provide prosthetic rehabilitation when required to support optimal oral function and quality of life.

#5

Seropositive rheumatoid arthritis in osteogenesis imperfecta type XI (FKBP10 mutation): first case report and literature review.

Orphanet journal of rare diseases2026 Jan 13

Osteogenesis imperfecta (OI) is a rare genetic disorder primarily caused by mutations in genes involved in type I collagen production. We report a 27-year-old female with genetically confirmed OI type XI (OI-XI) who experienced a delayed diagnosis of seropositive rheumatoid arthritis (RA), resulting in irreversible deformities. The patient had multiple congenital contractures and became wheelchair-dependent in early childhood. She received only one course of bone protection therapy in her lifetime. Two years prior to presentation, she developed bilateral hand pain, stiffness, and progressive deformities. The diagnosis of RA was confirmed based on clinical features, imaging, and high titers of anti-cyclic citrullinated peptide (anti-CCP) antibodies. Genetic analysis revealed a homozygous FKBP10 mutation (c.391 + 4 A > T), confirming OI-XI. Treatment with methotrexate, folic acid, and vitamin D led to symptom improvement and stabilization of deformities. This is the first reported case of RA in a patient with genetically confirmed OI-XI. The case underscores the importance of early detection and treatment of RA in individuals with OI to prevent irreversible joint damage. Not applicable.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC4.738 artigos no totalmostrando 197

2026

Medication-related osteonecrosis of the jaw in an adult with osteogenesis imperfecta: a case report.

Frontiers in oral health
2026

Research at the Paris Foundling Hospitals. Part 2: After the Revolution.

Neonatology
2026

Mechanical characterization of Col1a1 +/- osteogenesis imperfecta bone revealed altered mechanical stiffness heterogeneity across scales.

Cell biomaterials
2026

The Clinical Utility of Whole-Exome Sequencing in the Prenatal Diagnosis of Fetal Skeletal Dysplasia.

International journal of women's health
2026

Evaluation of Lung Disease in Adults with Osteogenesis Imperfecta: A Cross-Sectional, Multi-Center Study.

Chest
2026

Posterior spinal fusion with pedicle screw-based constructs in osteogenesis imperfecta: a systematic review of surgical and radiographic outcomes.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2026

Should exome sequencing Replace Chromosomal Microarray Analysis in Suspected Skeletal Dysplasias? Lessons from a Case of Osteogenesis Imperfecta.

Fetal diagnosis and therapy
2026

Elevated periostin level in serum of adults with Osteogenesis Imperfecta is associated with disease severity.

The Journal of clinical endocrinology and metabolism
2026

Evaluation of Fracture and Osteotomy Union in the Setting of Osteogenesis Imperfecta: Multicenter Reliability of the Modified Radiographic Union Score for Tibial Fractures (RUST).

Journal of pediatric orthopedics
2026

Lung scRNA-seq reveals chronic inflammation and emphysemous phenotype in mice with osteogenesis imperfecta.

Frontiers in genetics
2026

Deciduous pulp stem cell-derived extracellular vesicles stimulate the proliferation of cartilage progenitor cells via extracellular signal-regulated protein kinase 1/2 activation.

Scientific reports
2026

Journal of Bone and Mineral Research 40th anniversary celebration: the second decade (part 2).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2026

Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2026

Identification and functional characterization of a novel pathogenic COL1A1 splicing variant in a Chinese family with osteogenesis imperfecta.

Frontiers in genetics
2026

A radiological case series of three siblings with osteogenesis imperfecta and shared paternal inheritance.

Radiology case reports
2026

Evolution and outcomes of telescoping intramedullary rods in pediatric bone fragility disorders: A systematic review.

Journal of children's orthopaedics
2026

Co-Occurrence of Osteogenesis Imperfecta Type III and Chronic Abruption-Oligohydramnios Sequence: A Case Report Suggesting a Possible Role of Type I Collagen Fragility.

The journal of obstetrics and gynaecology research
2026

Telescoping rodding with adjunctive external fixation or threaded wires in osteogenesis imperfecta: evaluation of outcomes.

Journal of pediatric orthopedics. Part B
2026

Report of the favorable pregnancy outcomes in an FKBP10-related Bruck syndrome case and a narrative review of pregnancy in severe osteogenesis imperfecta.

BMC pregnancy and childbirth
2026

The Role of Non-coding RNAs in Connective Tissue Diseases: Diagnostic and Therapeutic Potential of miRNAs, lncRNAs and circRNAs.

Molecular diagnosis &amp; therapy
2026

Acute Phase Reaction After First Neridronate Infusion in Children with Osteogenesis Imperfecta: An Analysis Based on Questionnaire Data from 65 Patients.

Paediatric drugs
2026

Pressure-induced ossicular alterations in the oim mouse model of brittle bone disease do not cause hearing loss.

Hearing research
2026

Magnetically Controlled Intramedullary Compression Nailing for Femoral Nonunion in Osteogenesis Imperfecta: A Case Report.

JBJS case connector
2026

AI-driven multimodal imaging: unveiling hidden cardiac vulnerabilities in osteogenesis imperfecta.

Annals of medicine and surgery (2012)
2026

Perioperative Care of an Eleven-Year-Old Child With Osteogenesis Imperfecta Type II During Posterior Spinal Fusion.

Journal of medical cases
2026

Reclassification of variants of uncertain significance in type I collagen genes: a national reference laboratory experience.

Journal of medical genetics
2026

Osteogenesis Imperfecta with a gross deletion including the COL1A1 gene, induced by Alu-driven microhomology-mediated end joining.

Bone reports
2026

Inhibition of FGFR signaling with infigratinib improves linear bone growth in the female Aga2/+ mouse model of osteogenesis imperfecta.

JBMR plus
2026

Dual intramedullary nailing for lower limb deformities in pediatric osteogenesis imperfecta: Adaptive migration and clinical outcomes in a Vietnamese cohort.

Current problems in surgery
2025

Atypical femoral fractures in a Mexican cohort of children and adolescents with osteogenesis imperfecta. Analysis of trajectories.

Acta ortopedica mexicana
2026

Current advances of bone homeostasis imbalance in the cause of hereditary metabolic bone diseases.

EFORT open reviews
2025

Osteogenesis Imperfecta or Non-accidental Trauma? The Diagnostic Dilemma in Pediatric Fractures.

Journal of the Pediatric Orthopaedic Society of North America
2026

Development of a large porcine model of osteogenesis imperfecta type I.

Bone reports
2026

The Metacarpophalangeal Pattern Profile: An Old Method With New Insights Into the Evaluation of Short Stature.

American journal of human biology : the official journal of the Human Biology Council
2026

In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth.

Calcified tissue international
2026

Multiexon COL1A2 deletion as a rare mechanism in osteogenesis imperfecta: Case report and literature review.

Bone
2026

Addressing the unmet challenge of pain in rare bone diseases: new insights from the RUDY UK registry.

Orphanet journal of rare diseases
2026

A C-Propeptide Variant in COL1A1 Potentially Perturbing Disulfide Bonding in Osteogenesis Imperfecta Type III.

Congenital anomalies
2025

Extendable intramedullary nailing in a child with osteogenesis imperfecta of bilateral femoral fractures: a case report.

Frontiers in surgery
2026

A New Perspective on Osteogenesis Imperfecta: From Cellular Mechanisms to the Systemic Impact of Collagen Dysfunction.

International journal of molecular sciences
2026

Advancing Obstetric Care: The Role of Targeted Next-Generation Sequencing in Pregnancies with Structurally Normal Fetuses.

Journal of the Chinese Medical Association : JCMA
2026

Oral health-related quality of life in patients with osteogenesis imperfecta in Taiwan.

Journal of dental sciences
2026

Fixation Procedures of The Proximal Third Femur in Patients With Osteogenesis Imperfecta: Location, Location, and High Revision Rates.

Journal of pediatric orthopedics
2026

Missense mutation of BMP1 may cause feline osteogenesis imperfecta without bone deformity.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2026

Heritable metabolic bone disorders: a guide to current genetic testing and clinical management for adult endocrinologists.

Pathology
2026

Modeling rare genetic skeletal disorders with bone organoids: a narrative review.

Bone
2025

Clinical diagnosis and challenges in management of Osteogenesis Imperfecta in a resource-limited setting - A case report and review of literature.

International journal of surgery case reports
2026

Impact of preoperative halo-gravity traction on radiographic and surgical outcomes following posterior spinal fusion in osteogenesis imperfecta: a comparative study.

Spine deformity
2026

Post-translational modifications of collagen type I in osteogenesis imperfecta: Systematic review and meta-analysis.

Bone reports
2026

Seropositive rheumatoid arthritis in osteogenesis imperfecta type XI (FKBP10 mutation): first case report and literature review.

Orphanet journal of rare diseases
2026

Scoliosis surgery outcomes in the setting of osteogenesis imperfecta: a scoping systematic review and meta-analysis.

Spine deformity
2026

Biologics for bone regeneration: advances in cell, protein, gene, and mRNA therapies.

Bone research
2025

Revision of Cemented Reverse Total Shoulder Arthroplasty with Bone Graft in Osteogenesis Imperfecta: A Case Report.

Journal of orthopaedic case reports
2025

Management of a Case of Adult Mid-Shaft Femur Fracture in Osteogenesis Imperfecta by Long Proximal Femoral Nail: A Case report.

Journal of orthopaedic case reports
2026

Atypical Fracture From Bisphosphonate Use in Hypophosphatasia With Improved Bone Response to Teriparatide Therapy.

JCEM case reports
2026

Rare Variants in the P3H1 Gene in Patients With Osteogenesis Imperfecta of Bashkir Origin From Russia.

Clinical genetics
2026

A rare 5'UTR variant in SEC24D reveals translational dysfunction in osteogenesis imperfecta: a roadmap for RNA therapeutic rescue.

Scientific reports
2025

Histopathological Features in Osteogenesis Imperfecta Type III.

Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2026

Wormian bones: expanded differential diagnosis and implications for abnormal head shape in infancy.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2025

Case Report: A case of neonatal osteogenesis imperfecta: navigating critical care and early fracture management through multidisciplinary collaboration.

Frontiers in pediatrics
2025

Defying the Odds: Survival in Severe Prenatal Caffey's Disease.

Cureus
2025

Previously Unreported TMEM38B Variant in Osteogenesis Imperfecta Type XIV: A Case Report and Systematic Review of the Literature.

International journal of molecular sciences
2025

Boolean Networks with Classic and New Updating Modes Applied to Genetic Regulation in Some Familial Diseases.

International journal of molecular sciences
2025

Assessment of Collagen and Fibroblast Properties via Label-Free Higher Harmonic Generation Microscopy in Three-Dimensional Models of Osteogenesis Imperfecta and Ehlers-Danlos Syndrome.

International journal of molecular sciences
2025

Osteogenesis Imperfecta with Pes Equinovarus: A Rare Combination and a Rare Col1a1 Variant.

Journal of clinical research in pediatric endocrinology
2025

Surgical Strategies of Staged Spinal Traction-Fusion for Severe Scoliosis in Osteogenesis Imperfecta Type IV: A Case Report and Literature Review.

International journal of spine surgery
2025

Bathrocephaly and Serpentine Fibula as Underrated Features of Osteogenesis Imperfecta Type I: A Case Report.

Molecular syndromology
2025

Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone Disorders.

JACS Au
2026

Osteogenesis Imperfecta Type V With Undifferentiated Pleomorphic Sarcoma: A Rare Occurrence.

Pediatric blood &amp; cancer
2026

Exfoliation of primary dentition in children with Osteogenesis Imperfecta medicated with bisphosphonates.

European journal of paediatric dentistry
2025

Retrospective study on the outcomes of Fassier-Duval nailing and osteotomy for the treatment of long bone fractures or deformities in the lower extremities in children with osteogenesis imperfecta.

Frontiers in surgery
2025

A Novel Biallelic Variant in The SERPINH1 Gene in Two Siblings Diagnosed with Osteogenesis Imperfecta Type X: Evidence of Intrafamilial Clinical Variability.

Journal of clinical research in pediatric endocrinology
2025

Novel FKBP10 Mutation in Iranian Patients with Osteogenesis Imperfecta: Insights from Whole-Exome Sequencing to Molecular Dynamics.

Iranian biomedical journal
2026

Effect of bisphosphonate treatment on the oim mouse middle ear ossicles' structure, composition and hearing.

Bone
2025

Molecular drivers of osteogenesis imperfecta: a cellular and extracellular collagen disease.

Clinical science (London, England : 1979)
2026

Comprehensive evaluation of cochlear implantation in otosclerosis: radiological, technical, and audiological outcomes over five years.

Cochlear implants international
2026

Craniofacial and whole-skeleton fracture patterns in osteogenesis imperfecta: Findings from a nationwide U.S. insurance claims database.

Bone
2025

[Comprehensive considerations for the diagnosis, treatment, and management of osteogenesis imperfecta].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Clinical Outcome of Patients with Osteogenesis Imperfecta on Intravenous Pamidronate Treatment at the Philippine General Hospital from 2010-2018.

Acta medica Philippina
2025

Combined Treatment with a C-Type Natriuretic Peptide Analog and Bisphosphonate Enhances Bone Growth in Growing Mice with Osteogenesis Imperfecta: A Pilot Study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

The Role of Osteoblasts in Phenotypic Variability of Dominant Osteogenesis Imperfecta: Evidence from Patients and Murine Models.

International journal of molecular sciences
2026

Psychiatric Comorbidities and Treatment Modalities in Children With Osteogenesis Imperfecta: A Systematic Review of Mental Health.

American journal of medical genetics. Part A
2026

Genotype-based comparison of bone microstructure in adult patients with classical osteogenesis imperfecta.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2026

Impaired SERPINF1 Expression due to c.[-37C>A];[829_831del] Causes Osteogenesis Imperfecta VI.

American journal of medical genetics. Part A
2025

Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: the 'MOI-A' study; a randomised, phase 2/pilot, dose-escalating trial.

BMJ open
2025

Diaphragmatic Hernia in a Newborn With COL1A1-Associated Classical Ehlers-Danlos Syndrome.

Case reports in genetics
2025

Use of Analgesics in Osteogenesis Imperfecta in Denmark-A Nationwide Register-based Cohort Study.

Calcified tissue international
2025

Targeted fetal NGS panel reveals genetic conditions in sonographically normal fetuses: Insights from a large cohort study.

PloS one
2025

Temporal Bone CT Findings in Hajdu-Cheney Syndrome: Case Report with Review of the Literature.

AJNR. American journal of neuroradiology
2025

Pregnancy-Related Complications in Osteogenesis Imperfecta.

Obstetrics and gynecology
2025

Sarcopenia and Muscle Dysfunction in Osteogenesis Imperfecta: Insights from A Pilot Study.

Journal of musculoskeletal &amp; neuronal interactions
2025

The benefit of diet on paradoxical breathing and sleep in Osteogenesis imperfecta.

Orphanet journal of rare diseases
2026

Pre-operative zoledronate is safe for children with medical complexity undergoing posterior spinal fusion for neuromuscular scoliosis.

Spine deformity
2026

Pain intensity in patients with genetic metabolic bone diseases: an observational study.

Bone
2025

Clavicular Head Subluxation Resulting in Tracheal Compromise in an Osteogenesis Imperfecta Type III Patient: A Case Report.

Cureus
2025

Sandwich Allograft for Long-Bone Deformity Correction in Bone Dysplasia.

JBJS essential surgical techniques
2025

Assessment of cardiac function by speckle tracking echocardiography in children with osteogenesis imperfecta.

Pediatric research
2025

Fabric-elasticity relationships of femoral head trabecular bone are similar in Type 2 diabetes and non-diabetic individuals.

Bone reports
2025

FKBP10 Variants: Differentiation Between Bruck Syndrome Type 1 And Osteogenesıs Imperfecta Type XI.

Journal of clinical research in pediatric endocrinology
2026

Accuracy of dental age estimation methods in children with chromosomal syndromes: A systematic review and network meta-analysis.

Archives of oral biology
2025

Commentary on Quality Improvement Case Series: "Osteogenesis Imperfecta or Non-accidental Trauma".

Journal of the Pediatric Orthopaedic Society of North America
2025

Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta.

Calcified tissue international
2025

Mesenchymal Stem Cell Transplantation for Osteogenesis Imperfecta Patients: A Systematic Review.

Annals of the New York Academy of Sciences
2025

Double jaw surgery for a patient with Gnathodiaphyseal dysplasia (GDD): A case report and literature review.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2026

A novel variant of NOTCH2 causes skeletal fragility.

Bone
2026

Quantitative assessment of the temporomandibular joints in patients with osteogenesis imperfecta: a CBCT study.

Oral surgery, oral medicine, oral pathology and oral radiology
2025

Cochlear implantation in osteogenesis imperfecta: a case series on feasibility, challenges, and outcomes.

Cochlear implants international
2026

Molecular spectrum of autosomal recessive osteogenesis imperfecta in 93 Italian children with bone fragility: a monocentric experience.

Journal of endocrinological investigation
2025

Anesthetic management of children undergoing specialized orthopedic surgeries.

Journal of clinical orthopaedics and trauma
2025

Novel Insights From In Silico Analysis of Biallelic ALPL (c.1001G/A and c.571G/A) in Two Mennonite Families Leading to Hypophosphatasia.

Cureus
2025

Mitral Valve Aneurysm With Perforation Resulting in Severe Mitral Regurgitation Secondary to Infective Endocarditis: A Report of a Rare Case.

Cureus
2026

Identification of rare genetic variants in familial forms and unrelated cases of bisphosphonates-associated atypical femur fracture.

Joint bone spine
2025

Health-related quality of life in individuals with osteogenesis imperfecta in the United States: a cross-sectional study.

Orphanet journal of rare diseases
2025

Assessment of Bone Density in Osteogenesis Imperfecta in Pediatric and Adolescent Age Group: Can the Metacarpal Index Play a Role?

Indian journal of orthopaedics
2025

Peripheral Nerve Blocks in Patients With Osteogenesis Imperfecta Undergoing Extremity Procedures are Safe and Effective.

Journal of the Pediatric Orthopaedic Society of North America
2025

Intersecting Pathologies: COL1A1-Related Syndrome in the Setting of Childhood-Onset Hypopituitarism: Case Report and Literature Review.

Diagnostics (Basel, Switzerland)
2026

Genetic and Clinical Spectrum of Osteogenesis Imperfecta in an Egyptian Cohort With a High Rate of Lethal Phenotypes.

Clinical genetics
2025

Medication-Related Impacts on Pediatric Bone Health.

Journal of the Pediatric Orthopaedic Society of North America
2025

Pilot study to investigate sleep and breathing related complications in children and young people with osteogenesis imperfecta.

BMC musculoskeletal disorders
2026

Rates and Pattern of Antifracture Drug Use in 6475 Adults and Children With Osteogenesis Imperfecta.

The Journal of clinical endocrinology and metabolism
2025

Facilitators and barriers to care among individuals with osteogenesis imperfecta.

Psychology &amp; health
2025

Minimally Invasive Aortic Valve Replacement in Osteogenesis Imperfecta: A Case Report.

Surgical case reports
2025

CRTAP-Related Osteogenesis Imperfecta: Clinical Variability and a Potential Founder Variant in CRTAP.

Molecular syndromology
2025

New Lens On Congenital Mild Bone Fragility: a Novel Col1a1 Knockout Mouse Model for Osteogenesis Imperfecta Type 1.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Bone microstructural and strength changes over one year in children with osteogenesis imperfecta are comparable to age- and sex-matched healthy controls.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Comprehensive Bibliometric Assessment of the Top 50 Cited Articles on Osteogenesis Imperfecta.

Orthopedic reviews
2025

Somewhere to go: a position paper on addressing gaps in transition care for adults with childhood-onset rare diseases.

Orphanet journal of rare diseases
2025

Subarachnoid hemorrhage secondary to ruptured posterior inferior cerebellar artery aneurysm in a patient with type 3 osteogenesis imperfecta: A case report and topic review.

Surgical neurology international
2025

Involvement of patient organisations in research activities: actions taken and lessons learned in a clinical research study for osteogenesis imperfecta.

Orphanet journal of rare diseases
2025

Targeted Gene Sequencing in a Male Adult Diagnosed With X-Linked Osteoporosis Due to a Novel p.(Arg398Profs*2) PLS3 Variant.

JCEM case reports
2025

Clinical application of radiofrequency echographic multi-spectrometry (REMS) for diagnosis and follow-up in several rare bone disorders: a case series.

BMC medical imaging
2025

Surgical Technique for Revision of the Distally Migrated Fassier-Duval Femoral Rod in Osteogenesis Imperfecta: A Case Report.

Children (Basel, Switzerland)
2025

Tips and Tricks for Installation of the SLIM Nail in Osteogenesis Imperfecta with Narrow Medullary Canals: A Surgical Guide with Case Insights.

Children (Basel, Switzerland)
2025

The IMPACT Survey: The Humanistic Impact of Caring for an Individual with Osteogenesis Imperfecta.

Advances in therapy
2025

Cardiac manifestations in children with osteogenesis imperfecta: A single-center observational study.

International journal of cardiology
2025

RING-Box E3 Ligase Target N-Terminal Lysine 55 to Regulate Turnover of Sp7 Protein.

Journal of cellular biochemistry
2025

Pediatric Scoliosis in Osteogenesis Imperfecta: From Genetic Mechanisms to Therapeutic Strategies.

Orthopaedic surgery
2025

The IMPACT Survey: The Economic Impact of Caring for an Individual with Osteogenesis Imperfecta.

Advances in therapy
2025

Acceptability and Barriers of Exercise in Children With Osteogenesis Imperfecta.

Archives of rehabilitation research and clinical translation
2025

A rare case of McCune-Albright syndrome in a young male with hyperthyroidism and hypertrophic scars.

Oxford medical case reports
2025

Clinical and Functional Outcomes of Telescoping Intramedullary Nails in Pediatric Osteogenesis Imperfecta: A Multicenter Prospective Study With a One-Year Follow-Up.

Cureus
2025

Urinary calcium and bone resorption markers during 3 years of denosumab treatment in pediatric osteogenesis imperfecta.

JBMR plus
2025

Real-world data of fracture rates and musculoskeletal disorders for patients living with osteogenesis imperfecta.

JBMR plus
2025

A pictorial essay of thoracic wall diseases: multiple pathologies in the same anatomical site.

Insights into imaging
2025

Image-guided in vivo evaluation and comparison of bone-targeting peptides for therapeutic intervention.

Drug delivery and translational research
2025

Nanoscale Structural and Functional Impacts of Disease-Associated Collagen Mutations.

bioRxiv : the preprint server for biology
2026

Exome Sequencing Reveals Novel Variants in Genetic Skeletal Disorders: Insights From a Cohort in Southwest Iran.

Clinical genetics
2025

Osteogenesis imperfecta, intellectual disability and recurrent infections in a male with a pathogenic SASH3 variant.

Human genome variation
2026

Enhancing Wnt signaling lowers fracture incidence in a severe mouse model of Osteogenesis Imperfecta.

Bone
2025

Stanford Type B Aortic Dissection in a Patient With Osteogenesis Imperfecta: A Case Report.

Journal of investigative medicine high impact case reports
2025

A qualitative exploration of child, caregiver, and clinician perspectives on mental health in children with osteogenesis imperfecta.

Journal of child health care : for professionals working with children in the hospital and community
2025

Hip to Be Rare: The Intersection of Transient Osteoporosis and Osteogenesis Imperfecta.

Current sports medicine reports
2025

Clinical Characteristics and Management of Rare Metabolic Bone Diseases: An Audit of the Rare Metabolic Bone Disease Registry of India.

Calcified tissue international
2025

Challenges and solutions in the treatment of spinal disorders in patients with skeletal dysplasia: A comprehensive review.

World journal of methodology
2025

Addressing surgical challenges in patients with severe form of osteogenesis imperfecta and with prolonged bisphosphonate treatment: intramedullary sclerosis and technical solutions.

International orthopaedics
2026

Analysis of Orofacial Changes in Children and Adolescents With Mucopolysaccharidosis and Osteogenesis Imperfecta.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2025

A novel splice-altering frameshift variant in the COL1A1 gene underlies osteogenesis imperfecta type I: molecular characterization of a four-generation Chinese pedigree and literature review.

Human genomics
2025

Genotype-Phenotype Correlation Insights in a Rare Case Presenting with Multiple Osteodysplastic Syndromes.

Genes
2025

Serum Osteocalcin in Pediatric Osteogenesis Imperfecta: Impact of Disease Type and Bisphosphonate Therapy.

International journal of molecular sciences
2024

Qualitative investigation of school experiences in children with osteogenesis imperfecta.

Children's health care : journal of the Association for the Care of Children's Health
2025

A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases.

Therapeutic advances in musculoskeletal disease
2025

Assessment of bone mineral density by fractal dimension in OI patients treated with bisphosphonates.

BMC oral health
2025

LC3 and GABARAP independent autophagy of misfolded procollagen in mouse osteoblasts.

Autophagy
2025

Basilar invagination in osteogenesis imperfecta-Case report.

Radiology case reports
2025

Anisotropic mechanical properties of pediatric osteogenesis imperfecta bone in three-point bending between disease phenotypes and controls.

Journal of biomechanics
2025

Cranial bypass for occlusive carotid dissection in osteogenesis imperfecta: illustrative case.

Journal of neurosurgery. Case lessons
2025

Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models.

JBMR plus
2025

Co-occurrence of Congenital Osteogenesis Imperfecta and Maternal Antiphospholipid Syndrome: A Novel Case Report.

Cureus
2025

Medial Patellofemoral Ligament Reconstruction in Osteogenesis Imperfecta Using Modified Basket-Weave Technique: A Case Report.

JBJS case connector
2025

Application of the Gross Motor Function Measure in children with conditions other than cerebral palsy: A systematic review.

Developmental medicine and child neurology
2025

Mindful Self-Compassion to Reduce Pain Interference Among Adults with Osteogenesis Imperfecta.

Journal of clinical psychology in medical settings
2025

Moderately severe osteogenesis imperfecta-like osteochondrodysplasia associated with heterozygous variants in both COL1A2 and TRPV4.

JBMR plus
2025

Demographic and Clinical Profile of Patients with Osteogenesis Imperfecta Hospitalized Due to Coronavirus Disease (COVID)-19: A Case Series of 13 Patients from Brazil.

Healthcare (Basel, Switzerland)
2025

Mortality and fracture risk in children with osteogenesis imperfecta: Results from the French nationwide hospital discharge database.

Bone
2025

Clinical, Biochemical and Radiological Features of LRP5 Gene Variants in Children.

Calcified tissue international
2025

Gene editing for collagen disorders: current advances and future perspectives.

Gene therapy
2025

Pathological Rupture of the Quadriceps Tendon in a Patient With Osteogenesis Imperfecta With Leg-length Discrepancy: A Case Report.

Orthopedics
2025

A Scoping Review of Trainees With Motor and Sensory Disabilities in Surgical Specialties: Barriers, Representation, and Inclusive Solutions.

Journal of surgical education
2025

10-Year follow-up after balloon kyphoplasty in a 11-year-old child with type I osteogenesis imperfecta and T12 fracture.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2025

Intramedullary telescopic nailing method applied in cases with osteogenesis imperfecta and our results.

BMC musculoskeletal disorders
2025

Expanding the Genotypic and Phenotypic Spectrum of P3H1 Related Osteogenesis Imperfecta.

Calcified tissue international
2025

Lumbar disc herniation in osteogenesis imperfecta associated with a COL1A1 frameshift mutation: A case report and review.

Medicine
2025

Limb Length Discrepancy and Osteogenesis Imperfecta: Preventable or Inevitable?

Journal of pediatric orthopedics
2025

Using the simple locking intramedullary (SLIM) system for bone deformity stabilization: A retrospective cohort study.

Journal of children's orthopaedics
2025

Pediatric Bone Fractures: Challenges In Differential Diagnosis Between Child Abuse And Osteogenesis Imperfecta.

Annali di igiene : medicina preventiva e di comunita
2025

New Immunohistochemical Findings on Amelogenin and Dentin Sialophosphoprotein in Genetic Tooth Diseases.

International dental journal
2025

Children and Adolescents with Mucopolysaccharidosis and Osteogenesis Imperfecta: The Dentistry on the Multiprofessional Team.

Journal of personalized medicine
2025

A retrospective study on the prevalence, management, and outcomes of congenital heart diseases in children at Edward Francis small teaching hospital, banjul, the Gambia.

BMC cardiovascular disorders
2025

A Systematic Review on the Efficacy of Bisphosphonates on Osteogenesis Imperfecta.

Cureus
2025

Osteogenesis Imperfecta: A Look into the Cerebellum of the Brtl Murine Model.

Molecular neurobiology
2025

Endoplasmic reticulum stress and autophagy as potential therapeutic targets in SERPINF1 mutation-induced type VI osteogenesis imperfecta.

Life sciences
2025

Osteoclast-independent osteocyte dendrite defects in mice bearing the osteogenesis imperfecta-causing Sp7 R342C mutation.

Bone research
2025

Changes in lean mass and fat mass in children with Osteogenesis Imperfecta.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
2025

A Siglec-15 Antibody Promotes High Quality Bone Formation in Adult Female Mice With Osteogenesis Imperfecta.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society
2025

Hearing function and ossicular deformities and fractures in the oim mouse model of brittle bone disease.

Hearing research
2025

Molecular and Clinical Landscape of Osteogenesis Imperfecta: Unraveling Autosomal Recessive Forms, Therapeutic Outcomes, and Bone Mineral Density in Carriers.

Clinical genetics
2025

Molecular and Clinical Aspects of Osteogenesis Imperfecta Type VI: A Case Series with Novel SERPINF1 Gene Variants.

International journal of molecular sciences
Ver todos os 4.738 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Osteogenesis imperfecta.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Osteogenesis imperfecta e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A osteogênese imperfeita é causada por alterações genéticas que afetam a estrutura e a síntese do colágeno nos ossos. Pode ser transmitida de forma autossômica dominante, autossômica recessiva ou ligada ao cromossomo X, envolvendo genes como SERPINF1, PLS3 e IFITM5.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 7 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:666
    Orphanet
  2. GARD:1017
    GARD (NIH)
  3. Q749409
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Osteogenesis imperfecta. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/osteogenesis-imperfecta

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Osteogenesis imperfecta
Compêndio · Raras BR

Osteogenesis imperfecta

ORPHA:666 · MONDO:0019019
🇧🇷 Brasil SUS
SIGTAP
5 procedimentos
Geral
Prevalência
1-5 / 10 000
Herança
Autosomal dominant, Autosomal recessive, X-linked recessive
CID-10
Q78.0 · Osteogênese imperfeita
CID-11
Ensaios
26 ativos
Medicamentos
13 registrados
Início
All ages
Prevalência
8.06 (Worldwide)
MedGen
UMLS
C0023931
EuropePMC
Wikidata
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Alvos terapêuticos
fonte: OpenTargets
Rara